What gives you hope about the future of breast cancer? During October, join us in spreading some encouraging video messages from clinicians, researchers, caregivers, and patients.
From a physician perspective, Dr. Mike shares his knowledge of new technologies available today and on the horizon.
New hybrid modality of Opto-Acoustic/Ultrasound (OA/US) reveals the telltale signs of cancer with a painless, non-invasive scan to help diagnose breast cancer and reduce unnecessary biopsies.
Pioneered by Seno Medical, Opto-Acoustic/Ultrasound (OA/US) shines a new light on breast cancer diagnostics, enabling a real-time assessment to differentiate malignant from benign breast tissue.
Save patients the delay and worry of biopsy results with a single scan.How It Works
See the functional and anatomic features of questionable breast tissue.See Imaging
OA/US detects tumors as small as 3mm, identifying telltale signs of cancer.Clinical Insights
The technology behind the Imagio® Breast Imaging System
AI and Decision Support
AI and machine learning power an easy-to-use interface for reading results and objectively assign reference keys and translate imaging into diagnostic scalesView SenoGram® Brochure
Six separate images reveal the functional and anatomic features of breast tissue and immediately display features that differentiate tumor neoangiogenesisView Imagio® Brochure
How Seno's Technology Works
Seno’s opto-acoustic technology combines both laser optics and conventional ultrasound technology to provide fused functional and anatomical breast imaging in real time. The result is a diagnostic imaging tool that delivers additional functional information regarding suspicious breast masses and potentially increases confidence regarding the need for breast cancer diagnostic biopsies.Learn more »
Talk to a Seno Medical sales rep for more information about the latest technological advancements and how you can bring the novel combination of state-of-the-art ultrasound and groundbreaking opto-acoustic technology to your facility.